Company Overview

MaxiMaa Proyurveda has been an esteemed subsidiary of MaxiMaa group, associated with Colorado based ADFAC LABS, U.S.A. that continues its endeavor to manufacture and develop superior of pharmaceutical formulations making Ayurvedic in combination with Probiotics.

We develop Ayurvedic products and Probiotics, and conduct clinical trials utilizing the Platform of US Patent # 6080401. We has developed more than 150 products and conducted clinical trials and got the approval of the Drug Control & Department of AYUSH Administration.

We, have, ever since its inception, been flourishing with astute objectives envisioned to

	Create drugs, which can cure chronic arthritis, piles and nervous deceases without any side effects.
	Create drugs, which will improve general health of the human beings and also serve as preventive measures than clinical cures.
	Create a steady flow of income to INDIA by selling the herbs and Probiotics to the western Countries.
	Create a major employment in INDIA to enhance the quality of living of Indian People.

For more information, kindly visit to our website www.maximaaproyurveda.com